Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyProvidence SBRT/SRS Coverage Update | OpenPayer
    Ask Trek AI about this page
    CurrentProvidence Health PlanPolicy 229

    Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery

    Customize your policy alerts

    Sign up for Providence Health Plan Policy 229 alerts

    Get alerted when Policy 229 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity and coding requirements for SBRT and SRS services for Providence Health Plan, Providence Health Assurance, and Providence Plan Partners, primarily for commercial members. It applies to provider-submitted requests and claims, with separate direction for Oregon Health Plan and Medicare members.

    Policy Summary
    PayerProvidence Health Plan
    PolicyStereotactic Body Radiation Therapy and Stereotactic Radiosurgery
    Policy CodePolicy 229
    Change TypeAnnual review—no material changes
    Effective DateNovember 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateOctober 1, 2027
    Key ActionFor an unlisted code submitted for a potentially covered service, obtain prior authorization to avoid post-service denial.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    4
    SBRT procedure codes
    3SRS procedure codes
    8CPT and HCPCS codes
    1–5SRS treatment fractions
    11/2026Annual review

    Medical Necessity and Diagnosis-Code Coverage

    SBRT Medically Necessary Indications

    SBRT may be considered medically necessary when the applicable indication and documentation requirements below are met.

    ONE of the following indication pathways

    • Primary, non-metastatic tumor

      • Primary malignant tumor of the lung, liver, kidney, adrenal gland, pancreas, bone, or prostate; or primary malignant or benign tumor of the spine or spinal cord.
      • The patient's general medical condition, including performance status, justifies aggressive, curative treatment to the primary, non-metastatic tumor.

        The medical-necessity rationale and performance status must be specifically documented in the medical record.

    • Secondary, metastatic, recurrent, or previously irradiated tumor

      • Treatment is for a secondary or metastatic tumor, a recurrent tumor, or a tumor arising within or near a previously irradiated volume.
      • ONE of the following additional criteria

        • ALL of the following

          • The patient's general medical condition, including performance status, justifies aggressive local therapy to one or more deposits of metastatic cancer.
          • ONE of the following clinical objectives

            • Achieve total disease clearance in the setting of oligometastatic disease.
            • Reduce the patient's overall burden of systemic disease for a specifically defined clinical benefit.
        • Recurrent disease requires palliation, or the tumor cannot be treated as effectively or safely by other radiotherapy methods because of proximity to previously irradiated volumes and a high level of precision and accuracy is needed to minimize the risk of injury to surrounding normal tissues.

    SRS Medically Necessary Indications

    SRS may be considered medically necessary when at least one of the following indications is met.

    AT LEAST ONE of the following indications

    • Primary central nervous system malignancy, generally used as a boost or salvage therapy for lesions <5 cm.
    • Primary or secondary tumor involving the brain parenchyma, meninges/dura, or immediately adjacent bony structures.
    • Benign brain tumor, including meningioma, acoustic neuroma, other schwannoma, pituitary adenoma, pineocytoma, craniopharyngioma, glomus tumor, or hemangioblastoma.
    • Arteriovenous malformation or cavernous malformation.
    • Other cranial non-neoplastic condition, including trigeminal neuralgia; select medically refractory epilepsy; movement disorders such as Parkinson's disease or essential tremor; or hypothalamic hamartoma.

    Only diagnosis codes listed in the applicable SBRT or SRS diagnosis-code group qualify for coverage. Unlisted diagnosis codes billed with the corresponding procedure codes will deny as not medically necessary and not covered.

    All unlisted codes are reviewed at the claim level for medical necessity, correct coding, and pricing. If an unlisted code is submitted for a non-covered service addressed in this policy, it will be denied as not covered. If submitted for a potentially covered service, prior authorization is recommended to avoid a post-service denial.

    Diagnosis codes outside the listed SBRT diagnosis set are not covered when submitted with SBRT procedure codes.

    SBRT procedure codes 77373, 77435, G0339, and G0340 are considered medically necessary and covered only when billed with one of the listed SBRT ICD-10 diagnosis codes. All other diagnosis codes billed with these codes will deny as not medically necessary and not covered.

    SRS procedure codes 77371, 77372, and 77432 are considered medically necessary and covered only when billed with one of the listed SRS ICD-10 diagnosis codes. All other diagnosis codes billed with these codes will deny as not medically necessary and not covered.

    Procedure and Diagnosis Coding

    Covered SBRT CPT CodesCPTCovered
    77373Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions
    77435Stereotactic body radiation therapy, treatment management, per treatment course, to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions
    Covered SBRT HCPCS CodesHCPCSCovered
    G0339Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment
    G0340Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment
    Covered SBRT ICD-10 Diagnosis CodesICD-10Covered
    C00.0-C10.8ICD-10 diagnosis code range listed for SBRT codes
    C11.0-C14.8ICD-10 diagnosis code range listed for SBRT codes
    C19-C21.8ICD-10 diagnosis code range listed for SBRT codes
    C22.0-C22.9ICD-10 diagnosis code range listed for SBRT codes
    C25.0-C25.9ICD-10 diagnosis code range listed for SBRT codes
    C30.0-C32.9ICD-10 diagnosis code range listed for SBRT codes
    C34.00-C34.92ICD-10 diagnosis code range listed for SBRT codes
    C40.00-C41.9ICD-10 diagnosis code range listed for SBRT codes
    C51.0-C58ICD-10 diagnosis code range listed for SBRT codes
    C61ICD-10 diagnosis code listed for SBRT codes
    1–10 of 48
    1/5
    Covered SRS Procedure CodesCPTCovered
    77371Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course of treatment of cranial lesion(s) consisting of 1 session; multi-source Cobalt 60
    77372Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course of treatment of cranial lesion(s) consisting of 1 session; linear accelerator
    77432Stereotactic radiation treatment management of cranial lesion(s), complete course of treatment consisting of 1 session
    Covered CPT CodesCPTCovered
    77371Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course of treatment of cranial lesion(s) consisting of 1 session; multi-source Cobalt 60
    77372Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course of treatment of cranial lesion(s) consisting of 1 session; linear accelerator
    77373Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions
    77432Stereotactic radiation treatment management of cranial lesion(s), complete course of treatment consisting of 1 session
    77435Stereotactic body radiation therapy, treatment management, per treatment course, to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions
    Covered HCPCS CodesHCPCSCovered
    G0339Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment
    G0340Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment
    G0563Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions
    Covered ICD-10 Diagnosis Codes for 77373, 77435, G0339, and G0340ICD-10Covered
    C00.0-C10.8ICD-10 diagnosis code range listed for SBRT codes
    C11.0-C14.8ICD-10 diagnosis code range listed for SBRT codes
    C19-C21.8ICD-10 diagnosis code range listed for SBRT codes
    C22.0-C22.9ICD-10 diagnosis code range listed for SBRT codes
    C25.0-C25.9ICD-10 diagnosis code range listed for SBRT codes
    C30.0-C32.9ICD-10 diagnosis code range listed for SBRT codes
    C34.00-C34.92ICD-10 diagnosis code range listed for SBRT codes
    C40.00-C41.9ICD-10 diagnosis code range listed for SBRT codes
    C51.0-C58ICD-10 diagnosis code range listed for SBRT codes
    C61ICD-10 diagnosis code listed for SBRT codes
    1–10 of 48
    1/5
    Covered ICD-10 Diagnosis Codes for 77371, 77372, and 77432ICD-10Covered
    C11.0-C11.9ICD-10 diagnosis code range listed for SRS codes
    C30.0-C31.9ICD-10 diagnosis code range listed for SRS codes
    C69.31ICD-10 diagnosis code listed for SRS codes
    C69.32ICD-10 diagnosis code listed for SRS codes
    C69.41ICD-10 diagnosis code listed for SRS codes
    C69.42ICD-10 diagnosis code listed for SRS codes
    C69.91ICD-10 diagnosis code listed for SRS codes
    C69.92ICD-10 diagnosis code listed for SRS codes
    C70.0-C70.9ICD-10 diagnosis code range listed for SRS codes
    C71.0-C71.9ICD-10 diagnosis code range listed for SRS codes
    1–10 of 38
    1/4
    SBRT Poor Performance Status
    Karnofsky thresholdA Karnofsky Performance Status less than 40 is associated with treatment being considered not medically necessary.
    ECOG thresholdAn ECOG Performance Status of 3 or worse is associated with treatment being considered not medically necessary.
    Clinical implicationSBRT is not medically necessary when the patient has poor performance status, including either threshold above.
    SRS Essential Tremor Criteria
    Medication resistanceEssential tremor must not be controllable with medication.

    Authorization, Documentation, and Claim Adjudication

    Prior Authorization

    Prior Authorization for Unlisted Services

    For potentially covered unlisted services addressed by this policy, obtain prior authorization before service to reduce the risk of post-service denial. Unlisted codes are reviewed at the claim level for medical necessity, correct coding, and pricing.

    • Prior authorization is recommended for potentially covered unlisted services.
    • Unlisted codes submitted for non-covered services addressed in this policy will deny as not covered.
    Documentation Required

    Clinical Medical-Necessity Records

    Submit clinical records supporting medical necessity, including the patient’s medical history, physical examination findings, and current functional status. Document the applicable overall performance-status score, such as Karnofsky Performance Status or ECOG Performance Status.

    • Include medical history and physical examination findings.

    Therapy Overview

    Stereotactic Body Radiation Therapy (SBRT) is a radiation treatment modality that combines highly accurate, reproducible anatomic targeting with very high doses of precise external ionizing radiation. It is used primarily to treat extracranial targets while limiting injury to adjacent normal tissues. Stereotactic Radiosurgery (SRS) applies stereotactic guidance to intracranial and selected skull-base targets, generally delivering treatment in one to five fractions with approximately 1 mm targeting accuracy.

    Key Terms and Performance Scales

    Stereotactic Body Radiation Therapy (SBRT)
    Treatment modalitySBRT is a radiation treatment modality that combines a high degree of anatomic targeting accuracy and reproducibility with very high doses of extremely precise, externally generated ionizing radiation.
    Therapeutic intentSBRT maximizes the cell-killing effect on the target while minimizing radiation-related injury in adjacent normal tissues.
    Typical treatment siteSBRT is used to treat extracranial sites.
    Stereotactic Radiosurgery (SRS)
    Treatment definitionSRS is externally generated ionizing radiation used to inactivate or eradicate definite targets in the head without an incision.
    Fraction rangeFor this policy, SRS is strictly defined as radiation therapy delivered in one to five fractions.
    Policy Summary
    PayerProvidence Health Plan
    PolicyStereotactic Body Radiation Therapy and Stereotactic Radiosurgery
    Policy CodePolicy 229
    Change TypeAnnual review—no material changes
    Effective DateNovember 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateOctober 1, 2027
    Key ActionFor an unlisted code submitted for a potentially covered service, obtain prior authorization to avoid post-service denial.
    SourceLink
    On This Page
    Medical Necessity and Diagnosis-Code CoverageProcedure and Diagnosis CodingAuthorization, Documentation, and Claim AdjudicationTherapy OverviewKey Terms and Performance Scales
  1. Boost treatment for a larger cranial or spinal lesion initially treated with external beam radiation therapy or surgery, such as sarcoma, chondrosarcoma, chordoma, or nasopharyngeal or paranasal sinus malignancy.
  2. ALL of the following

    • Metastatic brain disease, independent of the number of lesions.
    • Systemic disease is stable, with otherwise reasonable survival expectations.
    • ANY of the following

      • Karnofsky Performance Status is 40 or greater and is expected to return to 70 or greater with treatment.
      • ECOG Performance Status is 3 or less and is expected to return to 2 or less with treatment.
  3. Relapse in a previously irradiated cranial site where additional stereotactic precision is required to avoid unacceptable radiation to vital tissue.
  4. Uveal or ocular melanoma.
  5. ALL of the following

    • Treatment is provided under Coverage with Evidence Development (CED).
    • The patient is enrolled in an IRB-approved clinical trial or a multiinstitutional patient registry adhering to Medicare CED requirements.
  6. Systemic disease or coagulopathyThe patient must have major systemic disease or coagulopathy.
    Surgical suitabilityThe patient must be unwilling or unsuitable for an invasive surgical procedure.
    Treatment lateralityCoverage is limited to unilateral thalamotomy.
    SRS Fractions and Targeting Accuracy
    Treatment courseSRS is delivered in one to five fractions.
    Targeting accuracySRS uses approximately 1 mm targeting accuracy.
    Treatment targetsThe definition applies to intracranial targets and selected tumors around the base of the skull.
  7. Include current functional status and the applicable Karnofsky or ECOG performance-status score.
  8. Documentation Required

    Radiation Oncologist Evaluation Required

    A radiation oncologist must evaluate the clinical and technical aspects of the proposed treatment and document the evaluation and resulting management decision in the clinical record.

    • Document the radiation oncologist’s clinical evaluation.
    • Document the technical evaluation and resulting management decision.
    Documentation Required

    Dose and Delivery Records

    Document the technical aspects of treatment planning and delivery, including the prescribed dose to the target and relevant dose-limiting normal structures, the actual dose delivered, and the dates of treatment delivery.

    • Prescribed target dose.
    • Prescribed dose to relevant dose-limiting normal structures.
    • Actual dose delivered and treatment-delivery dates.
    Denial Risk

    SBRT Denial Risk

    SBRT is not medically necessary when the applicable primary, metastatic, recurrent, or previously irradiated-volume criteria are not met or are not specifically documented. Denial also applies when treatment is unlikely to achieve clinical cancer control or functional improvement, the tumor cannot be completely targeted with acceptable risk, or performance status is inadequate.

    • Karnofsky Performance Status less than 40 or ECOG Status of 3 or worse.
    • Tumor burden cannot be completely targeted with acceptable risk to nearby critical normal structures.
    • Treatment is unlikely to result in clinical cancer control and/or functional improvement.
    Denial Risk

    SRS Denial Risk

    SRS is not medically necessary when the applicable indication criterion is not met, including when treatment is unlikely to produce functional improvement or clinically meaningful disease stabilization, or when expected clinical benefit is not achievable.

    • Widespread cerebral or extracranial metastases with limited life expectancy and unlikely benefit within the remaining life.
    • Poor performance status: Karnofsky Performance Status less than 40 or ECOG Performance greater than 3.
    • The applicable SRS indication criteria and expected benefit must be supported in the record.
    Denial Risk

    Essential Tremor SRS Limitations

    For essential tremor diagnoses G25.0-G25.2, SRS coverage is limited to patients whose condition cannot be controlled with medication, who have major systemic disease or coagulopathy, and who are unwilling or unsuited for invasive surgery. Coverage is further limited to unilateral thalamotomy.

    • Applicable diagnoses: ICD-10 G25.0-G25.2.
    • Medication does not control the condition.
    • Major systemic disease or coagulopathy is present and the patient is unwilling or unsuited for invasive surgery.
    • Treatment is limited to unilateral thalamotomy.
    Denial Risk

    Unlisted Diagnosis Code

    Diagnosis codes billed with covered stereotactic procedures must be among the ICD-10 diagnosis groups listed in this policy. All other diagnosis codes billed with the applicable procedure codes will deny as not medically necessary and not covered.

    • Use only policy-listed ICD-10 diagnosis groups with the applicable stereotactic procedure.
    • Diagnosis codes outside the policy-listed groups create denial risk.
    Denial Risk

    SBRT Diagnosis-Code Requirement

    For SBRT procedure codes 77373, 77435, G0339, and G0340, all diagnosis codes other than the ICD-10 groups listed in the policy will deny as not medically necessary and not covered.

    • Affected SBRT codes: 77373, 77435, G0339, and G0340.
    • Bill these codes only with the policy-listed ICD-10 diagnosis groups.
    Denial Risk

    SRS Diagnosis-Code Requirement

    For SRS procedure codes 77371, 77372, and 77432, all diagnosis codes other than the ICD-10 groups listed in the policy will deny as not medically necessary and not covered.

    • Affected SRS codes: 77371, 77372, and 77432.
    • Bill these codes only with the policy-listed ICD-10 diagnosis groups.
    Billing Rule

    Unlisted-Code Claim Review

    All unlisted codes are reviewed at the claim level for medical necessity, correct coding, and pricing. An unlisted code submitted for a non-covered service addressed in this policy will deny as not covered; an unlisted code for a potentially covered service should be submitted with prior authorization to avoid post-service denial.

    • Non-covered unlisted services: deny as not covered.
    • Potentially covered unlisted services: prior authorization is recommended before service.
    • Review includes medical necessity, correct coding, and pricing.
    Billing Rule

    Additional Claim Edits and Benefit Limitations

    Coverage and reimbursement remain subject to provider contracts, member benefits and eligibility, utilization audits, and applicable claim-edit rules. Codes may also be subject to CMS National Correct Coding Initiative procedure-to-procedure bundling edits and medically unlikely edits; this policy does not override NCCI or MUE requirements.

    • Code-list inclusion or omission does not guarantee reimbursement or coverage.
    • Check provider contracts, member benefits, eligibility, and potential utilization audits.
    • Apply CMS NCCI procedure-to-procedure edits and daily MUE limits.
    Stereotactic guidanceSRS is delivered via stereotactic guidance using a known three-dimensional reference system for high anatomic accuracy.
    Targeting accuracySRS provides approximately 1 mm targeting accuracy for intracranial targets and selected tumors around the base of the skull.
    Karnofsky Performance Status Scale
    Scale rangeThe Karnofsky Performance Status Scale ranges from 100 to 0.
    High score interpretationA score of 100 indicates normal activity with no complaints and no evidence of disease.
    Relevant thresholdA score of 40 indicates disability requiring special care and assistance; scores below 40 indicate more severe functional impairment.
    ECOG Performance Status Scale
    Scale rangeThe ECOG Performance Status Scale ranges from Grade 0 to Grade 5.
    Fully activeGrade 0 indicates that the patient is fully active and able to carry on all pre-disease activities without restriction.
    Relevant thresholdGrade 3 indicates limited self-care with confinement to bed or chair for more than 50 percent of waking hours.
    Severe impairmentGrade 4 indicates complete disability, with no ability to perform self-care and total confinement to bed or chair; Grade 5 indicates death.